Twist Bioscience Corp reports results for the quarter ended in December - Earnings Summary

Twist Bioscience

02/02/2024 19:12

* Twist Bioscience Corp  TWST.OQ  reported a quarterly
adjusted
loss of 75 cents​​ per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -74 cents.  The mean expectation of nine analysts for the
quarter was for a loss of 78 cents per share. Wall Street
expected results to range from -82 cents to -72 cents per share.
    * Revenue rose 31.8% to $71.50 million from a year ago;
analysts
expected $67.58 million. 
    * Twist Bioscience Corp's reported EPS for the quarter was a
loss
of 75 cents​.
    * The company reported a quarterly loss of $43.01 million.
    * Twist Bioscience Corp shares had fallen by 9.8% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.5%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Twist Bioscience
Corp is $36.00 
This summary was machine generated from LSEG data February 2 at
07:12 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.78          -0.75          Beat
 Sep. 30 2023      -0.92          -0.81          Beat
 Jun. 30 2023      -1.14          -0.78          Beat
 Mar. 31 2023      -1.12          -1.04          Beat